Home
Market Capitalization of Sun Pharma Advanced Research Company Ltd
![Image](/insights/_next/image?url=https%3A%2F%2Fstorage.googleapis.com%2Fassets.cdp.blinkx.in%2FBlinkx_Website%2Ficons%2Fsun-pharma-advanced-research-company-ltd.png&w=128&q=75)
Sun Pharma Advanced Research Company Ltd
NSE: SPARC
Market Cap
Key Highlights
- The Market Cap of Sun Pharma Advanced Research Company Ltd is ₹ 4742 crore as of 12 Feb 25 .
- The Latest Trading Price of Sun Pharma Advanced Research Company Ltd is ₹ 146.15 as of 12 Feb 15:30 .
![Image](/insights/_next/image?url=https%3A%2F%2Fstorage.googleapis.com%2Fassets.cdp.blinkx.in%2FBlinkx_Website%2Ficons%2Fsun-pharma-advanced-research-company-ltd.png&w=128&q=75)
Sun Pharma Advanced Research Company Ltd
NSE: SPARC
Share Price
Market Price of Sun Pharma Advanced Research Company Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
12 Feb 2025 | 146.15 |
11 Feb 2025 | 150.05 |
10 Feb 2025 | 156.55 |
07 Feb 2025 | 158.85 |
06 Feb 2025 | 159.55 |
05 Feb 2025 | 160 |
04 Feb 2025 | 159 |
03 Feb 2025 | 155.5 |
01 Feb 2025 | 158.9 |
31 Jan 2025 | 160.05 |
SWOT Analysis Of Sun Pharma Advanced Research Company Ltd
BlinkX Score for Sun Pharma Advanced Research Company Ltd
Asset Value vs Market Value of Sun Pharma Advanced Research Company Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Competitive Comparison of Market Cap
Key Valuation Metric of Sun Pharma Advanced Research Company Ltd
Historical P/E Ratio of Sun Pharma Advanced Research Company Ltd
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
Historical P/E Ratio of Sun Pharma Advanced Research Company Ltd
Historical Revenue of Sun Pharma Advanced Research Company Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Revenue of Sun Pharma Advanced Research Company Ltd
Historical EBITDA of Sun Pharma Advanced Research Company Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Sun Pharma Advanced Research Company Ltd
Historical Net Profit of Sun Pharma Advanced Research Company Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Sun Pharma Advanced Research Company Ltd
Dividend Payout Over Time
About Sun Pharma Advanced Research Company Ltd
- Sun Pharma Advanced Research Company Ltd. (SPARC) is a clinical stage bio-pharmaceutical company engaged in creating new drugs and delivery systems.
- The Company works on innovation and new product development for global markets.
- They undertake projects in research and technology for new chemical entities (NCE's) or new molecules, and novel drug delivery systems (NDDS). Sun Pharmaceutical Advanced Research Company Ltd was incorporated on March 1, 2006 as an innovative and development company.
- They commenced operations on March 22, 2006.
- As per Scheme of Arrangement, all assets and liabilities of the Innovative Research & Development business including Novel Drug Delivery System (NDDS) division of Sun Pharmaceuticals Industries' Research & Development undertaking stands transferred and vested in the Company with effect from Appointed date on February 28, 2007.
Sun Pharma Advanced Research Company Ltd News Hub
Sun Pharma Advanced Research Company reports consolidated net loss of Rs 95.90 crore in the June 2024 quarter
Net Loss of Sun Pharma Advanced Research Company reported to Rs 95.90 crore in the quarter ended Jun
Read more
05 Aug 24
Sun Pharma Advanced Research Company reports consolidated net loss of Rs 107.33 crore in the September 2024 quarter
Net Loss of Sun Pharma Advanced Research Company reported to Rs 107.33 crore in the quarter ended Se
Read more
04 Nov 24
Sun Pharma Advanced Research Company to convene board meeting
Sun Pharma Advanced Research Company will hold a meeting of the Board of Directors of the Company on
Read more
25 Oct 24
SPARC drops as Q2 net loss widens to Rs 107 crore
Net sales declined 39.29% year on year (YoY) to 12.86 crore in the quarter ended 30 September 2024.
Read more
04 Nov 24